- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
4
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
4 companies
AFT Pharmaceuticals
Market Cap: NZ$293.6m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.80
7D
7.3%
1Y
-12.5%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.017
7D
0%
1Y
41.7%
Pacific Edge
Market Cap: NZ$183.0m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.18
7D
0%
1Y
18.5%
Rua Bioscience
Market Cap: NZ$8.8m
Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.037
7D
-15.9%
1Y
-14.0%